Next, we evaluated the expression of CD49f (integrin α6), a known cervical cancer stem cell marker preferentially targeted by high risk HPVs [22] and found on CTCs of metastatic breast cancer patients [23]. This evidence concerns the gene ITGA6 and breast cancer.